Enhertu Poised To Rewrite The Standard Of Care After ESMO

 
• By Jessica Merrill
  
high jump
AZ/Daiichi's Enhertu raised the bar in advanced HER2-positive breast cancer • Source: Alamy
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category